Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • Markets
  • Media
  • News

Novo Nordisk’s Flexible Pricing Approach: Push for Broader Access, Innovative Payments

By Vandana Singh
November 27, 12:04 PM
Novo Nordisk A/S (NYSE: NVO) is reportedly discussing with healthcare systems to introduce innovative pricing arrangements for its popular weight 

LLY

Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • Markets
  • News

Sanofi/Regeneron’s Blockbuster Prescription Drug Dupixent Shows Additional Promise In Chronic Lung Disorder

By Vandana Singh
November 27, 10:17 AM
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (NASDAQ: SNY) announced the second Dupixent (dupilumab) Phase 3 chronic obstructive pulmonary disease (COPD) trial (NOTUS) showed that Dupixent&nb

REGN

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • Markets
  • News

GSK Frames A Comeback For Its Multiple Myeloma Drug Following Encouraging Phase 3 Data

By Vandana Singh
November 27, 8:57 AM
GSK plc (NYSE: GSK) announced headline 

GSK

Read More
2 minute read
  • Bonds
  • Broad U.S. Equity ETFs
  • Econ #s
  • Economics
  • Equities
  • ETFs
  • Large Cap
  • Macro Economic Events
  • News
  • Top Stories
  • Treasuries

Stocks Notch 4th Week Of Gains – Tech Falters As Yields Rise; Gold Steady At $2,000: Friday’s Market Recap

By Piero Cingari
November 24, 2:52 PM
U.S. stocks marked their fourth consecutive week of gains, the longest winning streak since June, in a week marked by thinner trading volumes due to the Thanksgiving and Black Friday holidays.

BBY

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Large Cap
  • Long Ideas
  • Price Target
  • Trading Ideas

Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts’ Expectations

By Piero Cingari
November 24, 2:34 PM
Several S&P 500 stocks are trading at discounts of over 40% compared to analysts' price targets, offering potential upside, but caution is needed.

ALB

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • Markets
  • Media
  • News

German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks

By Vandana Singh
November 24, 1:48 PM
Bayer AG (OTC: BAYRY) (OTC: BAYZF) reportedly held an investor call to address concerns after intense scrutiny from investors following a series of unforeseen setbacks, prompting questions about transparency surrounding its 

BAYRY

Read More
2 minute read
  • Equities
  • Events
  • Large Cap
  • Markets
  • News

Target Makes Customers’ Holiday Merrier With Exciting New Deals, Including 2-Day Cyber Monday Sale

By Lekha Gupta
November 24, 12:35 PM
Target Corp (NYSE: TGT) announced plans for its two-day Cyber Monday sale, which will 

TGT

Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • Markets
  • Media
  • News

Novo Nordisk’s Wegovy Eyes Asian Market Debut Despite Supply Crunch

By Vandana Singh
November 24, 11:44 AM
Novo Nordisk A/S (NYSE: NVO) reportedly plans to introduce its highly sought-after anti-obesity medication, Wegovy, in Japan on February 22, marking its inaugural entry into the Asian market despite facing 

NVO

Read More
1 minute read
  • Contracts
  • Equities
  • Large Cap
  • Markets
  • News

Semiconductor Firm STMicroelectronics Pens Deal With ERG For Renewable Energy Supply In Italy

By Lekha Gupta
November 24, 11:02 AM
STMicroelectronics NV (NYSE: STM) inked a fifteen-year Power Purchase Agreement (PPA) with ERG for the supply of renewable energy to its 

STM

Read More
1 minute read
  • Equities
  • Large Cap
  • Markets
  • Media
  • News
  • Penny Stocks

Swiss Mining Company Glencore Plans EV Battery Recycling Factory Outside Of Italy: Report

By Lekha Gupta
November 24, 8:34 AM
Glencore PLC (OTC: GLCNF) reportedly plans to build a pilot project for an electric vehicle (EV) battery recycling plant outside Italy while eyeing the island of Sardinia for a larger facility.

GLCNF

Posts pagination

Previous 1 … 160 161 162 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service